| Followers | 1 |
| Posts | 255 |
| Boards Moderated | 0 |
| Alias Born | 02/23/2024 |
Friday, December 13, 2024 2:23:42 PM
all information was available in the poster presentation in San Antonio, where I attended :) take care bears
Recent JAGX News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2026 08:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2026 08:34:03 PM
- Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF) • ACCESS Newswire • 06/30/2026 01:00:00 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing • GlobeNewswire Inc. • 06/26/2026 12:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/25/2026 01:15:57 PM
- Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend • ACCESS Newswire • 06/25/2026 01:00:00 PM
- Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs • ACCESS Newswire • 06/23/2026 01:00:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th • GlobeNewswire Inc. • 06/23/2026 12:35:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/22/2026 08:25:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/22/2026 01:17:24 PM
- Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program • ACCESS Newswire • 06/22/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2026 09:16:09 PM
- Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention • ACCESS Newswire • 06/18/2026 01:00:00 PM
- Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases • ACCESS Newswire • 06/12/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2026 01:00:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/08/2026 08:41:08 PM
- Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders • ACCESS Newswire • 06/08/2026 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/02/2026 08:10:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/29/2026 09:23:41 PM
- Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders • ACCESS Newswire • 05/28/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 01:10:06 PM
- Jaguar Health Compliant with Nasdaq Bid Price Rule • ACCESS Newswire • 05/27/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 09:22:44 PM
- Jaguar Health Reports First Quarter 2026 Financials • ACCESS Newswire • 05/20/2026 08:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:36:22 PM
